Lars Gullestad
1 clinical trials · Sponsor
| Record | Firm | Date |
|---|---|---|
| Cholesterol Lowering With EVOLocumab to Prevent Cardiac Allograft Vasculopathy in De-novo Heart Transplant Recipients (NCT03734211) | Lars Gullestad | 2019-06-10 |
Track Lars Gullestad automatically
Every clearance here is in the API, with alerts when new ones post.